Rational design of a novel peripherally-restricted, orally active CB1 cannabinoid antagonist containing a 2,3-diarylpyrrole motif

, , , , , , ,

Bioorganic & Medicinal Chemistry Letters, 20(15), 4573–4577 (2010) .

Add your rating and review

If all scientific publications that you have read were ranked according to their scientific quality and importance from 0% (worst) to 100% (best), where would you place this publication? Please rate by selecting a range.

0% - 100%

This publication ranks between % and % of publications that I have read in terms of scientific quality and importance.

Keep my rating and review anonymous
Show publicly that I gave the rating and I wrote the review